Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
The average brokerage recommendation (ABR) for Analog Devices (ADI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The average brokerage recommendation (ABR) for Sterling Infrastructure (STRL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
According to the average brokerage recommendation (ABR), one should invest in Citigroup (C). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
The firm’s valuation gives CleanSpark credit for its contracted Sandersville campus and prospective Texas leases, while treating additional sites as largely unpriced.
Keep this in mind about Sandisk.
Take-Two topped Wall Street's revenue and earnings estimates in the fiscal first quarter.
Energy stocks were declining premarket Friday, with the State Street Energy Select Sector SPDR ETF (
Needham cited stronger tenant demand through MARA’s Starwood partnership, but withheld a price target pending more detail on the joint venture’s economics.
Data from GlobalData’s Financial Deals Database shows the bank worked on three transactions with a combined value of $10.4bn.
The video game publisher reported first-quarter net bookings of $1.39 billion, slightly above its own guidance range
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]
Alphabet's recurring revenue businesses will boost its stock over the next decade.
Trade Desk Inc (NASDAQ:TTD) shares tumbled almost 30% in premarket trading on Friday after the digital advertising technology company reported second-quarter revenue and profit that missed Wall Street estimates and issued a third-quarter forecast far below expectations. The company posted...
SpaceX is poised to close out a pivotal week in the green, with the stock fighting higher over the past five sessions after reporting its first earnings report as a public company and the largest share unlock in its brief trading history.
SpaceX is poised to close out a pivotal week in the green, with the stock fighting higher over the past five sessions after reporting its first earnings report as a public company, and the largest share unlock in its brief trading history.
Advanced Micro Devices (NASDAQ:AMD) said Thursday it will acquire Taalas, a Toronto startup that hardwires entire AI models directly into silicon, for an undisclosed amount. The deal targets inference, the business of running trained models, which AMD projects may grow...
There's been a rush for bullish stock bets this week. More than 10 million call options tied to the State Street SPDR S&P 500 ETF Trust traded in a single session earlier this week, the highest one-day sum on record, according to Cboe Global Markets data.
Evaluate the expected performance of Cisco (CSCO) for the quarter ended July 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Besides Wall Street's top-and-bottom-line estimates for Pan American Silver (PAAS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Besides Wall Street's top-and-bottom-line estimates for Trimble (TRMB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Tutor Perini (TPC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Netflix stock looks attractive to value investors, especially to out-of-the-money (OTM) short-put investors. For example, a 2.0% yield for one month is available on a put option with a 5% lower strike price.
The company plans to require large commercial users of Qwen3.8-Max to share a portion of revenue, following a similar move by Moonshot AI
Atlassian (NasdaqGS:TEAM) appoints Ken Exner as Chief Product Officer for Enterprise and Emerging products. Exner brings roughly three decades of product leadership experience from Amazon Web Services and Elastic. The role centers on expanding Atlassian's enterprise solutions and security focused offerings. The move comes as demand grows for cloud tools with strong governance, compliance, and security features. For readers watching Atlassian's leadership moves and looking for more companies...
Honeywell International (HON) has come under fresh investor scrutiny after Honeywell Aerospace, recently spun off from the company, reported its first standalone earnings with results below expectations and a reduced sales growth outlook. See our latest analysis for Honeywell International. Honeywell International’s latest spin off news comes after a tough period for the stock, with the share price falling 43.52% over the past 90 days and 38.55% year to date, while the 1 year total...
NANO Nuclear Energy (NNE) stock is in focus after the company was selected by AFWERX for a SBIR Phase I contract centered on its KRONOS MMR Energy System for Air Force applications. See our latest analysis for NANO Nuclear Energy. The AFWERX contract and upcoming third quarter 2026 business update come after a mixed period for NANO Nuclear Energy, with the share price down 36.2% year to date but up over the past week, while the 1 year total shareholder return has declined 52.3%. If you want...
Moderna (NasdaqGS:MRNA) has initiated a Phase 1 clinical trial in Canada for its investigational mRNA vaccine targeting Bundibugyo ebolavirus. The program addresses a strain of Ebola that currently has no approved vaccine and is positioned as part of Moderna's broader infectious disease portfolio. The trial involves collaboration with CEPI and Canadian public health authorities, with a stated focus on access for low and middle income countries. This kind of targeted vaccine work highlights...
Investors have had plenty to consider this year. The broader bull market remains intact, but bouts of volatility have created meaningful pullbacks in individual stocks, leaving investors searching for opportunities where weakness could prove temporary rather than a sign of deeper trouble.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing oppor
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
